Breegi Scientific Inc. (BSI) is an international Boston-based medical technology company founded in 2014. They have developed the world's first portable, digital-native, and low-cost infant incubator platform called NICI™, aimed at reducing neonatal mortality and morbidity globally. NICI™ is a multi-functional data-driven clinical platform that provides critical NICU capabilities at less than 1% of the cost, size, and weight of standard hospital incubators. BSI's long-term vision is to ensure no babies die due to lack of access to neonatal incubators and to provide safe, affordable biocontainment solutions. Their second platform, the Negative Pressure SteriDome (NPS), emerged during the COVID-19 pandemic to protect frontline workers and has received Emergency Use Authorization from the FDA.